Determination of P-glycoprotein surface expression and functional ability after in vitro treatment with darunavir or raltegravir in lymphocytes of healthy donors
Massimo Tempestilli(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Leopoldo Paolo Pucillo(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Emanuele Nicastri(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Chiara Tommasi(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Federico Martini(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Elisa Gentilotti(University of Verona), Pasquale Narciso, Pasquale De Nardo(University of Verona)
Cited by 15
Related Papers
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
|Eurosurveillance|2020|714
High Seroprevalence of Antibodies to Human Herpesvirus-8 in Egyptian Children: Evidence of Nonsexual Transmission
|JNCI Journal of the National Cancer Institute|1999|140
Nucleic acid amplification tests on respiratory samples for the diagnosis of coronavirus infections: a systematic review and meta-analysis
|Clinical Microbiology and Infection|2020|104
Diagnostic accuracy of point-of-care tests in acute community-acquired lower respiratory tract infections. A systematic review and meta-analysis
|Clinical Microbiology and Infection|2021|103